Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma

Nasim Taghavi1, Sara Bagheri2, Alireza Akbarzadeh3

  • 1Dental Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Insights

CD57 expression and mode of invasion are key indicators for predicting survival in oral squamous cell carcinoma (OSCC) patients, independent of other immune markers. This finding aids in understanding OSCC prognosis.

Area of Science:

  • Immunology
  • Oncology
  • Pathology

Background:

  • Natural killer (NK) cells are crucial for anti-tumor immunity, particularly when MHC class I is reduced.
  • Decreased CD16 receptor expression on NK cells correlates with diminished cytotoxic activity.
  • Tumor cells can evade immune surveillance by producing transforming growth factor beta (TGF-β), impacting patient prognosis.

Purpose of the Study:

  • To investigate the prognostic value of CD57 and CD16 positive cells and TGF-β expression in oral squamous cell carcinoma (OSCC).
  • To determine the relationship between these markers and clinicopathological features in OSCC.

Main Methods:

  • Immunohistochemical analysis of CD57, CD16, and TGF-β expression in 57 OSCC samples.
  • Bivariate and multivariate analyses were employed to assess correlations with clinicopathological data and survival.

Main Results:

  • Multivariate analysis identified CD57 expression (HR 17.34, P < 0.001) and mode of invasion (HR 0.362, P = 0.038) as significant predictors of survival in OSCC.
  • No significant correlation was observed between CD57 expression and mode of invasion (P = 0.96).
  • No correlation was found between CD57, CD16, and TGF-β expression.

Conclusions:

  • CD57 expression and mode of invasion are independent prognostic factors for survival in oral squamous cell carcinoma.
  • These markers can aid in predicting patient outcomes in OSCC.

Related Concept Videos